NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines.

International journal of oncology

Volumn 22, Issue 6, 2003, Pages 1297-1302

  Tesei, Anna ^a   Ricotti, Luca ^a   Ulivi, Paola ^a   Medri, Laura ^a   Amadori, Dino ^a   Zoli, Wainer ^a  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DRUG DERIVATIVE; ISOENZYME; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PTGS1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN;

ADENOCARCINOMA; ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIVISION; CELL SURVIVAL; COLON TUMOR; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KINETICS; METABOLISM; PATHOLOGY;

ADENOCARCINOMA; ANTICARCINOGENIC AGENTS; ASPIRIN; CELL CYCLE; CELL DIVISION; CELL SURVIVAL; COLONIC NEOPLASMS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; KINETICS; MEMBRANE PROTEINS; PLATELET AGGREGATION INHIBITORS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TUMOR CELLS, CULTURED;

EID: 0042628209     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.22.6.1297     Document Type: Article

References (0)